- Joined
- 27 June 2010
- Posts
- 4,203
- Reactions
- 329
Imagion Biosystems operates within the medical device and imaging sector and is focused on developing the MagSense™ product and partnering with leading industry players to commercialise the MagSense™ instrument and associated diagnostic tests.
It is anticipated that IBX will list on the ASX during May 2017.
https://imagionbiosystems.com
It is anticipated that IBX will list on the ASX during May 2017.
https://imagionbiosystems.com